Mundy, Rosie M.
Baker, Alexander T.
Bates, Emily A.
Cunliffe, Tabitha G.
Teijeira-Crespo, Alicia
Moses, Elise
Rizkallah, Pierre J.
Parker, Alan L.
Funding for this research was provided by:
Medical Research Council (MR/N0137941/1, MR/N0137941/1)
Tenovus (PhD2015/L13, PhD2015/L13)
Cancer Research UK (C7838/A25173, C7838/A25173)
Wellcome Trust (517732, 517732)
Knowledge Economy Skills Scholarships (515374, 515374)
Cancer Research Wales (514472, 514472)
Article History
Received: 7 June 2023
Accepted: 27 July 2023
First Online: 26 September 2023
Competing interests
: A.L.P. is founder and CSO of Trocept Therapeutics. All other authors declare that they have no competing interests.